![]() ![]() It was reported in a study that the prevalence of severe mucositis was 35% to 65% and these patients are at risk of discontinuing the treatment ( 7). According to World Health Organization (WHO), in patients with H and N cancer that received high doses of radiation (6000 - 7000 GY), grade 3 and 4 mucositis reaches to 85%, but all patients get some degrees of mucositis ( 6). About 83% of patients need radiotherapy and at least 60% of them get mucositis ( 5). Mucositis is the most common complication of radiotherapy in these patients that is defined as inflammatory and/or ulcerative injuries of oral cavity and/or stomach and intestines ( 5). Radiotherapy is a common medical procedure used in such patients ( 4). These cancers lead to about 350,000 deaths, annually ( 2, 3). Also, surgery and radiotherapy are curative treatments for only about 3.2% of new cancer cases ( 1). The patients with head and neck (H and N) cancers include about 5% of cancer cases diagnosed, worldwide. Persian Medicine Traditional Medicine Mucositis Head and Neck Cancer 1. Therefore, not only the severity of mucositis and the average of MPS were significantly lower in drug group compared with control group, but also they were invariant during the study and showed no uptrend. ![]()
0 Comments
Leave a Reply. |